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Abstract
The cause that opponents of pet cloning support is indisputably a worthy one: namely, the protection of
animal welfare. And because this type of animal cloning appears, at least at first glance, to have no noble ends,
the public and most animal ethicists have been content to let the cause, rather than the arguments, carry the
day. There is an overwhelmingly negative view of companion animal cloning among the lay public, animal
advocacy organizations, and professional ethicists. But how sound are their arguments against pet cloning?
Can they withstand careful scrutiny?
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• Determine whether licenses are required 
for exports of product, spares, software, 
or technical data – identify countries for 
which licenses are required – ensure 
processes in place to prevent 
exports/transfers without appropriate 
authorizations. 
• Ensure the global engineering enterprise 
is aware of applicable trade controls, 
both dual-use and sanctions.  Ensure 
processes are in place to prevent 
transfers of technical data without 
appropriate authorizations. 
• Ensure the global sourcing enterprise 
(supply chain) is aware of applicable 
trade controls, both dual-use and 
sanctions.  Ensure processes are in place 
to prevent transfers of technical data 
without appropriate authorizations. 
• If business has controlled technical data, 
coordinate with HR to identify all 
employees who are not either U.S. 
nationals or permanent resident aliens; 
ensure processes are in place to prevent 
transfers of or access to technical data 
within the U.S. without appropriate 
authorizations. 
• Implement foreign visitors control 
program. 
• Ensure all servers with trade controlled 
technical data are appropriately 
protected – file protection, system 
administrators are U.S. nationals, and 
all technical support/service is 
performed by U.S. nationals.  
• Review all business operating processes 
and procedures for involvement of U.S. 
persons in transactions involving 
embargoed destinations. 
• Ensure Internet marketing channel 
appropriately protected – screen all 
users at the transaction level and limit 
use of wizards or other technical services 
without appropriate screening. 
• Ensure subsidiaries in Canada, the EU, 
and Mexico have mechanisms in place to 
address local blocking statutes. 
• Conduct comprehensive compliance 
audit of all new acquisitions within 30 
days of closing.  
• Monitor changes to regulations and 
keep processes current. 
• Review all business transaction 
documentation associated with 
government procurement at time of 
receipt for compliance with U.S. anti-
boycott regulations. 
 
The process of developing and managing 
an effective internal controls program can be 
challenging and expensive.  In assessing the 
value of such an investment, however, corporate 
management needs to consider a number of 
related factors: 
1) The cost of internal investigations of 
alleged violations can easily exceed 
any potential monetary fines, 
sometimes by several orders of 
magnitude; 
2) The tort exposure from the failure to 
identify a problem customer (e.g., 
one with terrorist connections that 
appears on a published government 
list) could be almost unlimited; and 
3) The reputational risk associated 
with any alleged violation could be 
significant; these regulations are 
maintained to protect U.S. national 
security and they are increasingly 
seen as a major tool in its war 
against terrorism. 
 
Bill Clements is a Partner in the Washington, 
DC office of Foley & Lardner LLP.  He 
specializes in compliance issues related to U.S. 
international trade controls and the Foreign 
Corrupt Practices Act. He agreed to write this 
article as a follow-up to a presentation he made 
at the Biotechnology Committee's annual 
meeting in Chicago in August 2005. 
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first glance, to have no noble ends,1 the public 
and most animal ethicists have been content to 
let the cause, rather than the arguments, carry 
the day.  There is an overwhelmingly negative 
view of companion animal cloning among the lay 
public, animal advocacy organizations, and 
professional ethicists.  But how sound are their 
arguments against pet cloning?  Can they 
withstand careful scrutiny?   
 There are three ethical objections given 
by pet cloning opponents: 1) the plight of 
unwanted animals; 2) the exploitation of 
grieving clients; and 3) the suffering of the 
animals involved in the cloning process (the 
donors, the surrogates, and the clones). An 
analysis of the various arguments given by 
opponents of pet cloning shows, however, that 
only one argument can survive critical reflection, 
and that argument – the concern about the 
suffering of the actual clones – is the issue on 
which the moral justification of pet cloning 
hinges and around which the moral debate 
ought to be focused. 
 Let's start with the plight of unwanted 
animals. The US pet overpopulation problem 
has been cited repeatedly as a central objection 
to companion animal cloning.  For example, the 
animal advocacy organization American Anti-
Vivisection Society writes, "While pet cloning 
firms currently are charging customers up to 
$50,000 for a cloned cat and as much as $2,995 
to 'bank' a dog's or cat's DNA for future cloning, 
millions of homeless animals of the same species 
are available in US shelters for a round $100, 
which is used to cover costs.  However, most 
animals in shelters are euthanized for lack of 
adopting homes."2  Says Humane Society 
President Wayne Pacelle, "The Humane Society 
of the United States opposes pet cloning because 
it is dangerous for the animals involved, it serves 
no compelling social purpose, and it threatens to 
add to the pet overpopulation problem.  It 
doesn't sit well with us to create animals through 
such extreme and experimental means when 
there are so many animals desperate for 
                                                                            
1  I have argued elsewhere about the potential benefits to 
companion animals in general.  Fiester,  "Creating Fido's 
Twin:  Is There Moral Legitimacy in Pet Cloning?," Hastings 
Center Report, 35, No. 4, 2005, pp. 34-39. 
2 AAVS, Pet Cloning: Separating Facts from Fluff (February 
16, 2005). 
homes."3  Bioethicists agree.  David Magnus, 
Director of the Stanford Center for Biomedical 
Ethics, argues, "The idea that somebody would 
spend $50,000 for a cat when they can go to any 
shelter and rescue one is absurd."4 
 What these arguments certainly get 
right is the staggering problem of unwanted 
animals in the United States. The National 
Council on Pet Population Study and Policy 
found that in 1997 alone, 2,329,978 dogs and 
1,759,743 cats entered shelters, and between 50-
70% of these animals were euthanized.5  By 
ASPCA estimates, 8-12 millions companion 
animals enter shelters, and 60-70% are 
euthanized.6  A similar number is cited in the 
2001 Humane Society report on the state of 
animals in the US.  According to that report, 4-6 
million dogs and cats were euthanized in 
shelters in 2001.7  These figures do not include 
the millions of stray animals in the country: the 
ASPCA estimates that 70 million stray dogs and 
cats live in the US.8   
 The connection between the pet 
overpopulation problem and pet cloning seems 
obvious: there are many wonderful pets ready to 
adopt, and adopting instead of cloning saves one 
animal from euthanasia; therefore, one ought to 
adopt rather than clone.  When we add to that 
argument the fact that each cat clone currently 
costs $30,000, which – if redistributed – could 
save thousands of animal lives, we appear to 
come to the conclusion that the money ought to 
be donated to shelters rather than devoted to the 
purchase of just one animal.  But there is a 
serious problem with this argument against 
companion animal cloning.  If we interpret the 
                                                                            
3 HSUS, "Cat Cloning is Wrong-Headed States the Humane 
Society of the United States" (February 14,2002), available 
at: http://hsus.org/ace/13214. 
4  P. Fimrite, "Cat Has 10 Lives, Thanks to $50,000 Cloning," 
San Francisco Chronicle (December 23, 2004). 
5 National Council on Pet Population Study and Policy, 
"Shelters Statistics Survey," 1994-7, available at: 
http://www.petpopulation.org/statsurvey.html.  
6 ASPCA, "Annual Shelter Statistics," available at 
http://www.aspca.org. 
7 P.G. Irwin, "Overview: The State of Animals in 2001," in 
The State of Animals 2001 (D.J. Salem and A.N. Rowan, eds) 
(Washington, DC: Humane Society Press, 2001). 
8 ASPCA, "Annual Shelter Statistics, " available at 
http://www.aspca.org. 
 
 8
above argument as the claim, "There are too 
many cats in the world, therefore we shouldn't 
be cloning more," then the flaw in the argument 
might be called the "Hangnail vs. Hemorrhage" 
problem.  In terms of cat "production," cloning 
represents a tiny hangnail, while we're currently 
hemorrhaging to death from intentional and 
unintentional breeding.  According to the 
Humane Society of United States, there are 
currently 77 million cats owned in US 
households, and only 11.5 million were adopted 
from shelters. 1  In other words, 66 million cats 
were either purchased from breeders or bred by 
owners (again, either because they wanted to 
breed their cats, or because they didn't spay or 
neuter them).  To date: there have been 6 cats 
cloned.  If there are too many cats in the world, 
and the quantity needs to be reduced to cure the 
unwanted animal problem, then we should focus 
on breeders and owners who don't spay.  After 
we have made a significant impact on the main 
source of the problem, then we can focus on the 
trivial contributors to the companion animal 
numbers. 
 One additional irony of this argument 
against companion animal cloning is that the 
only firm currently cloning cats commercially 
buys its donor eggs in the form of ovaries that 
have been procured at spay clinics.  The money 
that those spay clinics receive for the ovaries is 
used to spay other cats.  So, at least while pet 
cloning production remains extremely low, a pet 
cloning firm that indirectly supports the spaying 
of cats from this method of egg procurement 
reduces the future pet population 
 The second objection to pet cloning 
fares no better, namely, the exploitation of 
grieving clients.  On this argument, opponents 
argue that buying a clone necessarily means 
being deceived because without deceived clients 
there wouldn't be clients.  The idea here is that it 
is irrational to want to have a later-born genetic 
twin of a beloved pet, and if a client had an 
accurate understanding of what cloning was, he 
or she wouldn't want one.  For example, 
Lawrence Hinman, Director of the Values 
Institute, University of San Diego, argues, "We 
can produce a genetically identical copy of our 
pet, but we delude ourselves if we think we have 
somehow accomplished something by the 
                                                                            
1 HSUS, available at http://www.hsus.org. 
substitution."2  But this is not true.  For pet 
owners, cloning a pet is an expression of 
profound grief and loss of intrinsically valuable 
entity; therefore, having the identical twin of 
beloved animal is closest they can come to 
having some part of that animal "live on."  There 
is nothing irrational about this.  
 That leaves opponents with only one 
remaining objection: the suffering of animals 
involved in the process.  But there are problems 
here as well.  Opponents cite three groups of 
animals that suffer in the process of pet cloning: 
the donors, the surrogates, and the clones.  But 
the only firm cloning pets to date uses eggs 
procured from spay clinics, so there is no 
suffering of the donors – their owners had their 
ovaries removed to prevent future pregnancies 
(a cause pet cloning opponents fully embrace), 
so no procedure was performed on these animals 
for the enterprise of pet cloning. As for the 
surrogates, again in current practice, they are 
adopted after one pregnancy, so their suffering is 
equivalent to what a human woman goes 
through in a successful cycle of in vitro, but then 
they are adopted into homes.  This turns out to 
be, then, the equivalent of feline kidney 
transplant, to which no one seems to raise 
objections. 
 That leaves the health status of the 
clones, and here the opponents raise a serious 
moral issue. The public does not have access to 
the data about the number of stillbirths and 
early neonatal losses in this process, and there 
certainly are no long-term data on the health 
status and long-term outcomes for the actual 
clones.  Here is where the opponents should 
focus their energy in making sure that these 
legitimate animal welfare concerns are 
addressed. 
 
Dr. Fiester is a senior fellow at the University of 
Pennsylvania Center for Bioethics.  She 
specializes in the ethics of animal cloning.  She 
agreed to write this essay for the Biotechnology 
Committee as  follow-up to the presentation she 
gave at a program on pet cloning sponsored by 
the Section of Science & Technology at the 
annual meeting in August 2005. 
 
 
 
                                                                            
2 L.M. Hinman, "Rover is Not Replaceble – Forget Cloning," 
Los Angeles Times (August 28, 2004). 
